This provider of umbilical cord blood storage and ancillary services has seen 2 negative estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can last.
China Cord Blood currently holds a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Investors interested in the home health care industry may also consider stocks like AmSurg Corp. (AMSG), Amedisys Inc. (AMED) and RadNet, Inc. (RDNT). All the three stocks bear a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment